Taken together, our study suggested that mitochondrial dynamics and functions could be enhanced in 3D cultured breast cancer stem cell spheres, and that the AKT inhibitor AZD5363 has the potential to suppress stemness, and re-sensitize BCSCs to chemo drugs by regulating mitochondrial fusion. This evidence concerns the gene AKT1 and breast cancer.